H-Index & Metrics Best Publications

H-Index & Metrics

Discipline name H-index Citations Publications World Ranking National Ranking
Microbiology D-index 76 Citations 26,131 172 World Ranking 394 National Ranking 201
Medicine D-index 77 Citations 38,870 218 World Ranking 10905 National Ranking 5821

Overview

What is he best known for?

The fields of study he is best known for:

  • Antibiotics
  • Internal medicine
  • Bacteria

His scientific interests lie mostly in Staphylococcus aureus, Microbiology, Antibiotics, Surgery and Methicillin-resistant Staphylococcus aureus. Henry F. Chambers combines subjects such as Antibacterial agent, Disease and Virulence with his study of Staphylococcus aureus. His studies in Microbiology integrate themes in fields like Platelet, Molecular mass, Recombinant DNA and Glycoprotein.

His Antibiotics research is multidisciplinary, incorporating perspectives in Molecular epidemiology and Combination therapy. His Surgery research includes themes of Internal medicine, Dalbavancin and Intensive care medicine. His research in Intensive care medicine intersects with topics in Skin and skin structure infection, Antimicrobial, Soft tissue and Cellulitis.

His most cited work include:

  • Clinical Practice Guidelines by the Infectious Diseases Society of America for the Treatment of Methicillin-Resistant Staphylococcus aureus Infections in Adults and Children (2524 citations)
  • Waves of resistance: Staphylococcus aureus in the antibiotic era (1525 citations)
  • Practice Guidelines for the Diagnosis and Management of Skin and Soft Tissue Infections: 2014 Update by the Infectious Diseases Society of America (1262 citations)

What are the main themes of his work throughout his whole career to date?

Henry F. Chambers spends much of his time researching Microbiology, Staphylococcus aureus, Antibiotics, Methicillin-resistant Staphylococcus aureus and Internal medicine. His Microbiology study frequently links to other fields, such as SCCmec. His studies deal with areas such as Bacteremia and Endocarditis as well as Staphylococcus aureus.

His Antibiotics study combines topics in areas such as Antimicrobial and Drug resistance. His work carried out in the field of Methicillin-resistant Staphylococcus aureus brings together such families of science as Phenotype, Epidemiology, Immunology and Clindamycin. His research is interdisciplinary, bridging the disciplines of Surgery and Internal medicine.

He most often published in these fields:

  • Microbiology (47.44%)
  • Staphylococcus aureus (47.44%)
  • Antibiotics (27.99%)

What were the highlights of his more recent work (between 2017-2021)?

  • Antibiotics (27.99%)
  • Staphylococcus aureus (47.44%)
  • Internal medicine (19.80%)

In recent papers he was focusing on the following fields of study:

The scientist’s investigation covers issues in Antibiotics, Staphylococcus aureus, Internal medicine, Microbiology and Methicillin-resistant Staphylococcus aureus. His work deals with themes such as Dermatology, Infective endocarditis and Cohort, which intersect with Antibiotics. He has researched Staphylococcus aureus in several fields, including Endocarditis, Antimicrobial, Peptidoglycan, Molecular biology and Antibiotic resistance.

His Internal medicine research is multidisciplinary, incorporating elements of Bacteremia and Carbapenem-resistant enterobacteriaceae. His Microbiology research integrates issues from Klebsiella pneumoniae and Gene. As a part of the same scientific study, Henry F. Chambers usually deals with the Methicillin-resistant Staphylococcus aureus, concentrating on Bicarbonate and frequently concerns with Beta.

Between 2017 and 2021, his most popular works were:

  • Essential Resources and Strategies for Antibiotic Stewardship Programs in the Acute Care Setting. (39 citations)
  • The Emperor's New Clothes: PRospective Observational Evaluation of the Association Between Initial VancomycIn Exposure and Failure Rates Among ADult HospitalizEd Patients With Methicillin-resistant Staphylococcus aureus Bloodstream Infections (PROVIDE). (35 citations)
  • Molecular and clinical epidemiology of carbapenem-resistant Enterobacterales in the USA (CRACKLE-2): a prospective cohort study (23 citations)

In his most recent research, the most cited papers focused on:

  • Antibiotics
  • Internal medicine
  • Bacteria

Henry F. Chambers mainly investigates Antibiotics, Internal medicine, Staphylococcus aureus, Bacteremia and Clinical trial. To a larger extent, Henry F. Chambers studies Microbiology with the aim of understanding Antibiotics. His work on Penicillin, Multiple drug resistance and Nafcillin as part of general Microbiology research is frequently linked to Lactam, bridging the gap between disciplines.

The various areas that Henry F. Chambers examines in his Internal medicine study include Tetracycline and Population study. Staphylococcus aureus and Infectious Disease Medicine are commonly linked in his work. Henry F. Chambers has included themes like Infectious disease, Vancomycin, Etest and Intensive care medicine in his Bacteremia study.

This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.

Best Publications

Clinical Practice Guidelines by the Infectious Diseases Society of America for the Treatment of Methicillin-Resistant Staphylococcus aureus Infections in Adults and Children

Catherine Liu;Arnold Bayer;Sara E. Cosgrove;Robert S. Daum.
Clinical Infectious Diseases (2011)

4042 Citations

Waves of resistance: Staphylococcus aureus in the antibiotic era

Henry F. Chambers;Frank R. DeLeo.
Nature Reviews Microbiology (2009)

2456 Citations

Practice Guidelines for the Diagnosis and Management of Skin and Soft Tissue Infections: 2014 Update by the Infectious Diseases Society of America

Dennis L. Stevens;Alan L. Bisno;Henry F. Chambers;E. Patchen Dellinger.
Clinical Infectious Diseases (2014)

2064 Citations

The changing epidemiology of Staphylococcus aureus

Henry F. Chambers.
Emerging Infectious Diseases (2001)

1988 Citations

Practice Guidelines for the Diagnosis and Management of Skin and Soft-Tissue Infections

Dennis L. Stevens;Alan L. Bisno;Henry F. Chambers;Henry F. Chambers;E. Dale Everett.
Clinical Infectious Diseases (2005)

1816 Citations

Methicillin resistance in staphylococci : Molecular and biochemical basis and clinical implications

Henry F. Chambers.
Clinical Microbiology Reviews (1997)

1443 Citations

Community-associated meticillin-resistant Staphylococcus aureus

Frank R DeLeo;Michael Otto;Barry N Kreiswirth;Henry F Chambers.
The Lancet (2010)

1429 Citations

Daptomycin versus Standard Therapy for Bacteremia and Endocarditis Caused by Staphylococcus aureus

Vance G. Fowler;Helen W. Boucher;G. Ralph Corey;Elias Abrutyn.
The New England Journal of Medicine (2006)

1407 Citations

The Sanford guide to antimicrobial therapy

David N. Gilbert;Robert C. Moellering;George M. Eliopoulos;Henry F. Chambers.
(2010)

1167 Citations

A Controlled Clinical Trial of E5 Murine Monoclonal IgM Antibody to Endotoxin in the Treatment of Gram-Negative Sepsis

Richard L. Greenman;Roland M. H. Schein;Michael A. Martin;Richard P. Wenzel.
JAMA (1991)

957 Citations

If you think any of the details on this page are incorrect, let us know.

Contact us

Best Scientists Citing Henry F. Chambers

Michael J. Rybak

Michael J. Rybak

Eugene Applebaum College of Pharmacy and Health Sciences

Publications: 244

Arnold S. Bayer

Arnold S. Bayer

University of California, Los Angeles

Publications: 148

Vance G. Fowler

Vance G. Fowler

Duke University

Publications: 113

Michael Otto

Michael Otto

National Institutes of Health

Publications: 92

Ronald N. Jones

Ronald N. Jones

JMI Laboratories

Publications: 83

George Sakoulas

George Sakoulas

University of California, San Diego

Publications: 78

Michael R. Yeaman

Michael R. Yeaman

University of California, Los Angeles

Publications: 73

François Vandenesch

François Vandenesch

École Normale Supérieure de Lyon

Publications: 72

Helio S. Sader

Helio S. Sader

JMI Laboratories

Publications: 71

Barry N. Kreiswirth

Barry N. Kreiswirth

Center for Discovery and Innovation

Publications: 71

Hermínia de Lencastre

Hermínia de Lencastre

Rockefeller University

Publications: 70

Cesar A. Arias

Cesar A. Arias

The University of Texas Health Science Center at Houston

Publications: 69

G. Ralph Corey

G. Ralph Corey

Duke University

Publications: 69

David P. Nicolau

David P. Nicolau

Hartford Hospital

Publications: 65

Alexander R. Horswill

Alexander R. Horswill

University of Colorado Denver

Publications: 62

Keiichi Hiramatsu

Keiichi Hiramatsu

Juntendo University

Publications: 61

Something went wrong. Please try again later.